EQT

Noema Pharma AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company focuses on developing innovative therapeutic products for orphan neurological disorders characterized by imbalanced neuronal networks. Its research and development efforts are dedicated to addressing disabling symptoms associated with conditions affecting the nervous system, such as Tuberous Sclerosis Complex, Trigeminal Neuralgia, and Tourette syndrome. By creating novel therapies, Noema Pharma aims to enhance the quality of life and improve patient outcomes for those suffering from these challenging disorders.

Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

IntegrityNext is a Munich-based company founded in 2016 by Martin Berr-Sorokin that specializes in supply chain compliance and sustainability monitoring. The company offers a cloud-based platform that enables businesses to oversee their suppliers' compliance with regulatory requirements, thereby reducing risk. Its platform automates the collection of supplier self-assessments and certificates, while also monitoring social media for potential malpractice and reputational threats. With features such as automated risk alerts, a pre-built supplier questionnaire, and a real-time dashboard, IntegrityNext assists small and medium-sized enterprises in translating complex compliance data requirements from international regulations into effective processes and systems. This comprehensive approach to supply chain compliance supports organizations in achieving greater transparency and accountability in their operations.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.

Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

SHL Medical AG specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989 and headquartered in Zug, Switzerland, the company serves pharmaceutical and biotech firms around the globe. In addition to its core product offerings, SHL Medical provides comprehensive services such as final assembly, labeling, and packaging. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring that it delivers innovative and reliable solutions tailored to meet the needs of its clients.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, founded in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a critical microRNA responsible for pathological changes in the heart resulting from stress or injury. Through its innovative approach, Cardior Pharmaceuticals seeks to address significant unmet medical needs in cardiovascular health.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

FoRx Therapeutics AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company is dedicated to developing innovative therapeutics for cancer treatment, specifically targeting key molecular pathways associated with DNA replication stress. By focusing on these novel pathways, FoRx aims to create first-in-class compounds that provide a new approach to targeted anticancer therapies. Through its research and development efforts, FoRx Therapeutics seeks to advance the healthcare industry's capabilities in combating cancer effectively.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks aimed at rural and suburban areas. As a pioneering provider in the industry, the company focuses on delivering fiber-to-the-home (FTTH) connections to private households, businesses, and public institutions. By collaborating closely with municipalities, Deutsche Glasfaser aims to facilitate nationwide broadband expansion, contributing significantly to Germany's digital progress. The company is recognized for its innovative and cost-efficient approaches to fiber optic deployment, positioning itself as a technology leader in the market. With substantial backing from experienced investors, Deutsche Glasfaser has emerged as one of the strongest providers in Germany's telecommunications landscape.

SHL Medical AG specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989 and headquartered in Zug, Switzerland, the company serves pharmaceutical and biotech firms around the globe. In addition to its core product offerings, SHL Medical provides comprehensive services such as final assembly, labeling, and packaging. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring that it delivers innovative and reliable solutions tailored to meet the needs of its clients.

Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

SUSE is a global leader in open source solutions, providing reliable and enterprise-grade software to a diverse range of industries, including automotive, telecom, banking, healthcare, manufacturing, retail, and technology. With a strong focus on Enterprise Linux, Kubernetes Management, and Edge solutions, SUSE supports mission-critical workloads for over 60% of the Fortune 500 companies. The company emphasizes collaboration with partners and communities to empower customers to innovate across various environments, from data centers to the cloud and edge. SUSE offers consulting, blended services, and training and certification, primarily generating revenue from subscriptions. Headquartered in Nuremberg, Germany, SUSE employs nearly 2,000 people globally and derives a significant portion of its revenue from North America.

MediFox GmbH, founded in 1994 and headquartered in Hildesheim, Niedersachsen, Germany, specializes in developing software solutions for ambulatory nursing care service providers and nursing care homes. The company offers enterprise system software designed to support outpatient care services, inpatient facilities, and therapeutic practices. MediFox's software encompasses essential services such as resource and route planning, care and support documentation, management information systems, and administration services, including billing and factoring. By providing these tools, MediFox enables care providers to enhance their organizational structure and streamline their processes in response to evolving industry needs.

BBS Automation GmbH is a provider of automation solutions and engineering services, specializing in the design, development, manufacturing, and installation of automated assembly and testing systems. The company serves a diverse range of industries, including automotive, aerospace, life sciences, consumer goods, electronic devices, energy storage, and renewable energy. BBS Automation also offers leak detection, build-to-print services, and winding technology solutions, along with training and after-sales support. With nearly 550 employees, the company operates production sites in Germany, China, Malaysia, and the United States, partnering with prominent global clients. Founded in 1891 and headquartered in Garching bei München, Germany, BBS Automation is committed to delivering flexible and high-quality automation solutions for complex manufacturing and testing processes.

Simplify Medical, Inc. is a medical device company specializing in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs intended for spinal use. Founded in 2013 and based in Sunnyvale, California, it offers innovative products such as the Simplify Disc, a non-metallic, MRI-compatible artificial cervical disc that preserves motion while allowing for full diagnostic imaging without the need for traditional CT scans. This technology minimizes patient exposure to ionizing radiation and is tailored for skeletally mature patients undergoing reconstruction at one level from C3 to C7 following discectomy procedures. Simplify Medical markets its products through distributors in the United Kingdom, Germany, and other international markets. The company was previously known as Simplify Delaware, Inc. before rebranding in February 2015.

Studienkreis is one of Germany's largest providers of professional tutoring services, operating nearly 1,000 tuition schools nationwide since its establishment in 1974. The company specializes in providing offline and digital tutoring aimed at primary and secondary school students, offering support across all major subjects through its proprietary teaching materials and scientifically backed learning methodologies. Studienkreis focuses on helping children and adolescents enhance their academic performance and achieve consistently good grades. In addition to addressing specific academic queries, the company emphasizes fostering independent learning skills and a sense of responsibility in students, thereby improving their overall confidence in their educational journey.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

DentConnect is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. DentConnect is headquartered in the Netherlands and serves over one million patients through its pan-European network of over 220 clinics. DentConnect acts as a multi-functional service organization for these clinics, allowing the dentists to fully focus on providing patients with the best possible care. DentConnect Shared Service Center supports and facilitates dentists with HR, Finance and administration, quality and care management, procurement, marketing and communication and general management.

Two modern and strategically located office buildings in suburban Frankfurt.

Simplify Medical, Inc. is a medical device company specializing in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs intended for spinal use. Founded in 2013 and based in Sunnyvale, California, it offers innovative products such as the Simplify Disc, a non-metallic, MRI-compatible artificial cervical disc that preserves motion while allowing for full diagnostic imaging without the need for traditional CT scans. This technology minimizes patient exposure to ionizing radiation and is tailored for skeletally mature patients undergoing reconstruction at one level from C3 to C7 following discectomy procedures. Simplify Medical markets its products through distributors in the United Kingdom, Germany, and other international markets. The company was previously known as Simplify Delaware, Inc. before rebranding in February 2015.

Open Systems AG, established in 1990 and headquartered in Zurich, Switzerland, specializes in providing comprehensive managed security services to global enterprises, NGOs, and institutions. The company offers a range of services, including network security, application delivery, identity management, and global connectivity, ensuring secure and reliable IT networks and business-critical applications. Open Systems' offerings encompass distributed and enterprise firewall services, WAN encryption, network security monitoring, and incident response, among others. Serving diverse sectors such as finance, healthcare, and government, the company aims to deliver effective security solutions tailored to clients' unique needs.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, founded in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a critical microRNA responsible for pathological changes in the heart resulting from stress or injury. Through its innovative approach, Cardior Pharmaceuticals seeks to address significant unmet medical needs in cardiovascular health.

GETEC is a prominent group of energy service providers operating across Germany and Europe, employing nearly 1,400 individuals. The company offers a comprehensive range of energy services in the liberalized energy market, focusing on energy efficiency, system design, and zero emissions. GETEC aims to guide clients through the complexities of the energy landscape by developing tailored solutions that extend beyond traditional energy considerations. Their approach emphasizes sustainability, efficiency, economic viability, and resource conservation, which are fundamental principles of their corporate philosophy. By providing integrated system solutions, GETEC creates added value for clients and supports them in improving their carbon footprint, with a commitment to future generations.

GlobalConnect is a prominent alternative provider of fiber network, data center, and managed hosting services in Northern Europe, primarily focusing on Denmark and Germany. Established in 1998 by Niels Zibrandtsen, the company operates a 12,500 km optical fiber network and manages approximately 13,000 square meters of data center space. GlobalConnect offers a range of services including bandwidth connectivity, colocation, and cloud infrastructure, catering to both enterprises and consumers. With a workforce of over 200 employees, the company is dedicated to delivering fast and reliable networking solutions, enhancing connectivity and technological capabilities for its clients across Sweden, Norway, Denmark, Finland, and Northern Germany.

GETEC is a prominent group of energy service providers operating across Germany and Europe, employing nearly 1,400 individuals. The company offers a comprehensive range of energy services in the liberalized energy market, focusing on energy efficiency, system design, and zero emissions. GETEC aims to guide clients through the complexities of the energy landscape by developing tailored solutions that extend beyond traditional energy considerations. Their approach emphasizes sustainability, efficiency, economic viability, and resource conservation, which are fundamental principles of their corporate philosophy. By providing integrated system solutions, GETEC creates added value for clients and supports them in improving their carbon footprint, with a commitment to future generations.

CHEP is a leading global provider of supply chain solutions, specializing in enhancing efficiency and sustainability for its customers. The company offers a range of services, including asset management and repair for unit load devices (ULDs), galley carts, and ground support equipment through its CHEP Aerospace Solutions division, headquartered in Zurich, Switzerland. This division manages the world's largest independent fleet of ULDs and operates a comprehensive global network for the maintenance and repair of containers, pallets, and inflight food service equipment. By providing tailor-made outsourcing solutions, CHEP enables airlines to focus on their core operations of transporting passengers and cargo while achieving significant cost savings and operational benefits. The company serves over 80 airlines worldwide, leveraging its unique capabilities and insights to help clients improve their logistics and supply chain management.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

kfzteile24 GmbH, established in 2001 and headquartered in Berlin, Germany, is a prominent retailer of automotive spare parts and accessories. The company operates primarily online via its platforms www.kfzteile24.de and www.autoteile24.de, offering a comprehensive range of products such as exhaust systems, axle suspension components, batteries, heaters, interior fittings, and braking systems at competitive prices. To complement its online distribution, kfzteile24 maintains three physical retail stores in Berlin, each with an affiliated repair shop for customer support. The company has experienced continuous growth since its founding, becoming one of Germany's largest online retailers for auto parts and accessories, with sales in the triple-digit million range.

Kuoni Destination Management is a Switzerland-based company that specializes in providing comprehensive destination management services for the travel and hospitality industries. The company focuses on event solutions, offering a range of services that include event development, budgeting, creative direction, and logistical support for virtual, hybrid, and live events. Its expertise encompasses entertainment, audiovisual technology, transportation, and coordination of activities such as gala dinners and public events. Kuoni Destination Management aims to deliver innovative and memorable experiences while ensuring seamless execution and attention to detail in all aspects of event planning and management.

Apleona is a professional services firm based in Neu Isenburg, Germany, established in 2016. The company specializes in comprehensive real estate services within the DACH region (Germany, Austria, and Switzerland). Its offerings span facility management, building technology, interior fittings, and real-estate management, including commercial services like letting, leasing, and marketing. Apleona caters to a diverse client base comprising banks, investment funds, industrial companies, and insurance firms, aiming to enhance their operational performance across multiple locations.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

kfzteile24 GmbH, established in 2001 and headquartered in Berlin, Germany, is a prominent retailer of automotive spare parts and accessories. The company operates primarily online via its platforms www.kfzteile24.de and www.autoteile24.de, offering a comprehensive range of products such as exhaust systems, axle suspension components, batteries, heaters, interior fittings, and braking systems at competitive prices. To complement its online distribution, kfzteile24 maintains three physical retail stores in Berlin, each with an affiliated repair shop for customer support. The company has experienced continuous growth since its founding, becoming one of Germany's largest online retailers for auto parts and accessories, with sales in the triple-digit million range.

Kuros Biosciences AG is a biopharmaceutical company based in Schlieren, Switzerland, dedicated to the discovery, development, and commercialization of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has developed a robust pipeline of biopharmaceuticals targeting chronic diseases. Its key products include Neuroseal, a novel biomaterial for dural sealing, and the MagnetOs family of bone graft substitutes used in orthopedic, spinal, and dental applications. MagnetOs is approved for use in the EU and the US, with further formulations under development for regulatory submission. Kuros also has a range of clinical-stage products, including KUR-111 and KUR-113, which have completed Phase II clinical trials for treating specific bone fractures. The company has engaged in significant clinical research, enrolling over 600 patients in multinational trials, generating promising data regarding safety and efficacy in various applications, particularly within orthobiologics.

HusCompagniet A/S is a prominent house builder primarily operating in Denmark, with expanding activities in Sweden and Germany. The company specializes in the design, sale, and delivery of customizable single-family detached houses, which are largely constructed on-site on land owned by customers. Additionally, HusCompagniet offers semi-detached houses to both consumers and professional investors, and produces prefabricated wood-framed houses under the VårgårdaHus brand in Sweden. Headquartered in Horsens, Denmark, the company has established a strong market presence, being three times larger than its nearest competitor in Denmark. Since its incorporation in 2015, HusCompagniet has achieved significant revenue growth and has been recognized as House Builder of the Year in Denmark for three consecutive years, employing around 230 people and delivering over 1,000 houses annually across its markets.

Neuravi Limited, established in 2009 and based in Galway, Ireland, specializes in designing and developing medical devices for treating acute ischemic strokes. The company's primary product, the EmboTrap revascularization device, is designed to restore blood flow by removing clots from blocked brain arteries. Neuravi operates in multiple European countries and is a subsidiary of DePuy Ireland Unlimited Company.

Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Evidensia Djursjukvård AB is a veterinary clinic chain headquartered in Stockholm, Sweden, operating over 180 clinics and hospitals across Sweden, Norway, Denmark, Finland, Germany, Holland, and Switzerland. The company provides a comprehensive range of animal care services, including veterinary care, food, medicine, and supplies for various pets, such as dogs, cats, small animals, exotic animals, and horses. Through its extensive network, Evidensia aims to deliver quality veterinary services to pet owners in multiple countries.

Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

Charleston Holding is an operator of nursing homes and residential care facilities in Germany, focused on serving physically and mentally impaired residents. The company adopts a buy-and-build strategy within the nursing home market, aiming to enhance its portfolio through acquisitions. Charleston provides a range of services, including nursing care, preventative care, and intensive care, along with assisted living and daycare options. By offering these services, Charleston Holding seeks to improve the quality of life for its residents and support their well-being into old age.

Swiss Smile is a dental service provider based in Switzerland, established in 2003 by Haleh Bronner and Golnar Signer. The company specializes in a comprehensive range of dental treatments that include prevention, preservation, tooth extraction and replacement, teeth straightening, beautification, medical procedures, and hygiene treatments. In addition to these services, Swiss Smile also conducts dentistry classes in schools, promoting dental health education. With operations in several cities including Zurich, Baden, Bulach, St. Moritz, Suhr, and Winterthur, Swiss Smile aims to deliver high-quality dental care to a diverse clientele across the region.

EEW Energy from Waste GmbH is a German company specializing in waste incineration and the generation of energy from waste. Founded in 1873 and based in Helmstedt, it operates 37 modern plants across 19 locations, efficiently recycling approximately five million tons of waste annually. The company produces climate-neutral electricity, process steam, and district heating, serving around 500,000 households. EEW Energy from Waste is committed to environmentally friendly waste disposal and resource conservation, utilizing by-products such as slag for road construction. With a workforce of 1,300 employees, the company continually strives to enhance its processes and efficiency through research collaborations with universities. EEW Energy from Waste emphasizes safe waste disposal for local councils and businesses while providing innovative energy solutions designed for the future.

Internetstores GmbH is a German-based company, established in 2003, that operates both online and physical retail stores specializing in bicycles and outdoor products. Its offerings include a wide range of bikes, sportswear, accessories, and outdoor adventure gear, catering to both recreational and hobbyist customers. With a presence in Germany, Sweden, and France, the company maintains retail stores in these countries and has additional offices in Esslingen, Stuttgart, Berlin, Lyon, and Stockholm. As a subsidiary of Signa Retail GmbH, internetstores operates as a multi-store e-commerce platform, serving customers across Europe.

Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

United Digital Group is a digital communication and marketing agency based in Hamburg, Germany, founded by Michael Riese in 1999. The company focuses on delivering comprehensive digitalization strategies and branding solutions to various industries, including finance, cosmetics, and jewelry. It offers a range of services, including consulting, analytics, business application redesign, brand management, and e-learning. Additionally, United Digital Group specializes in technology strategy, strategic planning, content production, affiliate marketing, dashboard development, channel planning, data analytics, and project management, positioning itself as a versatile partner for businesses seeking to enhance their digital presence and operational efficiency.

Sapiens Steering Brain Stimulation GmbH is a medical device company focused on advancing deep brain stimulation (DBS) therapy. Founded in 2011 as a spin-out of Royal Philips Electronics, Sapiens operates from offices in Eindhoven, the Netherlands, and Munich, Germany. The company is dedicated to developing a high-resolution, MRI-compatible DBS system designed to enhance patient comfort and improve therapeutic outcomes, particularly for individuals with Parkinson's disease. Sapiens’ innovative approach includes a unique steering brain stimulation system and image-guided programming, both of which are based on patented technologies.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Activaero GmbH is a drug delivery company specializing in controlled breathing technologies designed for the pulmonary delivery of inhaled therapeutic agents. Founded in 2004 and based in Gemunden, Germany, with additional locations in Munich and Dublin, Ohio, Activaero develops innovative devices such as AKITA, which utilizes smart card technology for efficient drug delivery, and Watchhaler, specifically designed for children requiring inhaled medication. The company also offers AKITA², a technology for use in clinical trials, and LimiX, a flow limitation valve that regulates inhalation flow rates. In addition to its product offerings, Activaero provides measurement and diagnostic technologies for laboratory applications, including aerosol property measurement systems. Furthermore, the company engages in contract development and clinical trial logistics services, marketing its products through a network of distributors. Activaero's solutions aim to improve therapy outcomes for patients suffering from severe respiratory diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, and idiopathic pulmonary fibrosis.

AcadeMedia is the largest independent education provider in Northern Europe, offering a comprehensive range of educational services from pre-schools to adult education. The company operates approximately 550 units primarily in Sweden, Norway, and Germany. Its educational segments include preschools, compulsory schools, upper secondary schools, and adult education, with the upper secondary school segment generating the highest revenue. AcadeMedia's upper secondary school brands include Praktiska, Drottning Blanka, NTI, LBS, ProCivitas, and Rytmus. The majority of the company's revenue is derived from its operations in Sweden, reflecting its strong presence in the region's education sector.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

Sausalitos Holding GmbH, established in 1994 and headquartered in Munich, Germany, operates a chain of casual dining pubs. It specializes in offering a diverse range of food and drinks, with a focus on Californian-Mexican cuisine and unique gastronomic cocktails. The company is recognized as one of the leading leisure restaurant chains in Germany, providing dining options for breakfast, lunch, and dinner.

PharmaZell GmbH is a German company that specializes in the development and production of generic active pharmaceutical ingredients (APIs), controlled substances, and amino acids. Founded in 1947 and headquartered in Raubling, Germany, it operates production facilities in Switzerland, Italy, and India, along with a sales branch in the United States. The company provides services for formulation development and regulatory documentation, catering to both originator and generic pharmaceutical sectors. With a focus on delivering tailored solutions through a flexible technology platform, PharmaZell aims to address the specific needs of its clients across the global pharmaceutical industry. The company is committed to ethical practices and prioritizes environmental responsibility, ensuring that it maintains strong relationships with its business partners and employees.

Okairos AG is a biopharmaceutical company headquartered in Basel, Switzerland, with operations in Rome and Naples, Italy. The company specializes in the discovery and development of genetic T-cell vaccines, focusing on conditions such as hepatitis C virus. Okairos also excels in gene delivery technologies, providing expertise in scalable viral-vector manufacturing processes. This enables other biotech firms to transition genetic vaccines and medicinal products from preclinical stages to commercial readiness, utilizing advanced good manufacturing practice (GMP) facilities. Previously a subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, Okairos is dedicated to advancing innovative therapeutic solutions in the healthcare sector.

Scandic Hotels Group is a Sweden-based hotel operator with a portfolio of over 200 hotels across approximately 120 destinations, primarily in the Nordic region. The company caters to both corporate and leisure travelers, with a significant portion of its revenue generated from business travel, room services, restaurants, and conferences. Scandic Hotels operates in several countries including Sweden, Finland, Denmark, Norway, Belgium, Poland, and Germany, with Sweden serving as the largest market. This extensive network enables the company to offer a diverse range of accommodations and services tailored to meet the needs of its guests.

CBR is a fashion company based in Isernhagen, Germany, specializing in women's apparel. The company is known for its efficient business model, producing twelve collections annually for each of its labels. This approach allows CBR to provide its retail partners with a high speed of turnover and responsiveness to market trends. CBR operates both retail and outlet stores, as well as an online platform, enabling it to reach a broad customer base and offer a diverse range of fashionable clothing to women.

4-Antibody AG is a biopharmaceutical company based in Basel, Switzerland, specializing in the development of human antibody therapeutics with a focus on immuno-oncology. Founded in 2002, the company utilizes its proprietary Retrocyte Display technology, which generates therapeutic antibody drug candidates from human antibody libraries expressed in mammalian B-lineage lymphocytes. In addition to providing its drug discovery platform to pharmaceutical partners, 4-Antibody is actively developing a pipeline of preclinical antibody programs targeting various immune checkpoints, including GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3.

Pfaff-silberblau's lifting and material handling business includes wire rope winches, chain hoists, rack and pinion jacks and hand pallet trucks. Its actuator business designs, develops, manufactures and markets components for lifting and motion control, including worm gear screw jacks, linear motion precision screws and quick lifting screw jacks. Based in Kissing, Germany, Pfaff-silberblau employs over 300 people and is represented worldwide through six international subsidiaries as well as numerous regional representatives.

U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Professor Axel Ullrich. Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.

DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH).

Metall Technologie Holding is a German manufacturer specializing in heat treatment industrial furnaces and related technologies. The company produces a variety of furnace types, including vacuum furnaces, continuous furnaces, atmosphere furnaces, and protective gas furnaces. Its products cater to diverse industries such as aeronautics, automotive, medical, steel manufacturing, and heat treatment contracting, serving clients globally. Metall Technologie Holding's furnaces are utilized for a wide range of applications, including gas and oil quenching, brazing of aluminum and stainless steel, sintering, metal injection molding, tempering, annealing, magnetic annealing and stabilization, aging and stress relieving, as well as low-pressure carburizing, nitriding, and cryogenic treatment.

SPORTFIVE is an international sports marketing agency that operates as a subsidiary of Lagardère SCA, having rebranded from Lagardère Sports UK Limited in May 2020. Established in 1998 and headquartered in Wilmslow, United Kingdom, SPORTFIVE employs approximately 500 individuals across its offices in Europe and Asia. The agency boasts over 25 years of industry experience and is recognized as a leader in sports marketing, particularly in Germany, where it manages marketing rights for numerous top-tier professional football clubs, as well as rights in handball, winter sports, and motorsports. In France, SPORTFIVE collaborates closely with various clubs, federations, and events, while in Africa, it serves as the exclusive marketing and media agent for the Confédération Africaine de Football (CAF). The agency provides a comprehensive range of services, including sponsorship and brand partnerships, athlete management, content creation, and media rights, effectively connecting rights holders, athletes, and brands with diverse opportunities in the sports and entertainment sectors.

4-Antibody AG is a biopharmaceutical company based in Basel, Switzerland, specializing in the development of human antibody therapeutics with a focus on immuno-oncology. Founded in 2002, the company utilizes its proprietary Retrocyte Display technology, which generates therapeutic antibody drug candidates from human antibody libraries expressed in mammalian B-lineage lymphocytes. In addition to providing its drug discovery platform to pharmaceutical partners, 4-Antibody is actively developing a pipeline of preclinical antibody programs targeting various immune checkpoints, including GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3.

Nederman Holding AB is an industrial equipment manufacturer focused on developing, producing, and marketing solutions to extract and manage hazardous substances such as fumes. The company operates through four main segments: Extraction & Filtration Technology, Process Technology, Duct & Filter Technology, and Monitoring & Control Technology. Its products aim to improve air quality, enhance sustainability, and ensure compliance with emissions regulations in industrial settings. Nederman serves a global market, with significant operations in regions such as Sweden, Germany, the UK, the US, and parts of Asia. The majority of its revenue is derived from the Extraction & Filtration Technology segment, reflecting its commitment to reducing the harmful effects of industrial processes and protecting both people and the environment.